Results 181 to 190 of about 33,667 (245)

Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone. [PDF]

Open Heart
Szakál I, Komlósi F, Tóth P, Arnóth B, Bohus G, Vámosi P, Szegedi N, Salló Z, Osztheimer I, Perge P, Orbán G, Kardos A, Merkely B, Gellér L, Nagy KV.   +14 more
europepmc   +1 more source

Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists. [PDF]

Medicina (Kaunas)
Karkoulias S, Leontsinis I, Iliakis P, Kallenou L, Tsiavos A, Soulaidopoulos S, Dri E, Manta E, Vlachakis PK, Tsioufis P, Ktenopoulos N, Karakasis P, Dimitriadis K, Patsalis PC, Chrysohoou C, Tsioufis K.   +15 more
europepmc   +1 more source

Steroid hormone antagonism affords vascular protection in a mouse model of vascular Ehlers-Danlos syndrome. [PDF]

JCI Insight
Juzwiak EE, Bowen CJ, Edwards R, Restrepo L, Lee S, Parks CA, Zeng A, Black MM, Reyes Gaido OE, Bramel EE, Shigaki DT, Beer MA, Bellini C, Dietz HC, Gallo MacFarlane E.   +14 more
europepmc   +1 more source

Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing's Syndrome. [PDF]

Case Rep Endocrinol
Sydney GI, Ntelis S, Majumdar SK.
europepmc   +1 more source

PASNA syndrome with overlapping <i>CACNA1D</i> and <i>MED12L</i> variants: expanding the spectrum. [PDF]

JCEM Case Rep
Nalluri BT, Kudugunti N, Sahay RK, Santhoju V.   +3 more
europepmc   +1 more source

Apparent mineralocorticoid excess with a novel <i>HSD11B2</i> variant: longitudinal clinical and biochemical follow-Up. [PDF]

JCEM Case Rep
Nalluri BT, Kudugunti N, Sahay RK.
europepmc   +1 more source

Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration. [PDF]

Drugs Drug Candidates
Al-Horani RA, Goyal N.
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists for Liver Fibrosis: Potential Mechanisms and Research Progress. [PDF]

J Clin Transl Hepatol
Zheng H, Feng Y.
europepmc   +1 more source

Abiraterone-Induced Hypokalemia and Hypophosphatemia: A Case Report. [PDF]

Cureus
Safi A, Fayyaz A, Veerban F, Jahangir S, Vishal H, Akatibo E, Kouyate G, Mallappallil M, Puri I, Mohamed I, Azhar M.   +10 more
europepmc   +1 more source

Review of Hyperkalemia Profile for Mineralocorticoid Receptor Antagonist in Patients with Chronic Kidney Disease and Type 2 Diabetes.

Cardiorenal Med
Kendrick JB, Dixon AM.
europepmc   +1 more source